Comparison of markers for fetal inflammatory response syndrome: Fetal blood interleukin‐6 and neonatal urinary β₂‐microglobulin

Abstract

We suggest that measuring urinary beta(2)-MG in premature infants soon after birth can monitor FIRS and may provide information on the risk of subsequent CLD development that is as clinically important as information derived from umbilical cord blood IL-6.